Coherus BioSciences, Inc. (CHRS) financial statements (2021 and earlier)

Company profile

Business Address C/O DENNIS M. LANFEAR
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:541503456193178171112
Cash and cash equivalents541292225193178165106
Short-term investments 211232  56
Other undisclosed cash, cash equivalents, and short-term investments0  0 0(0)
Restricted cash and investments     00
Receivables1571611721671429077
Inventory, net of allowances, customer advances and progress billings443527161084
Inventory443527161084
Other undisclosed current assets2528201814912
Total current assets:767727676395343276206
Noncurrent Assets
Inventory, Noncurrent48515449453018
Finance lease, right-of-use asset12     
Operating lease, right-of-use asset101011121111 
Property, plant and equipment  107666
Intangible assets, net (including goodwill)4444444
Goodwill1111111
Intangible assets, net (excluding goodwill)3333333
Restricted cash and investments00000 1
Other noncurrent assets2120010
Other undisclosed noncurrent assets99    6
Total noncurrent assets:74778171665135
TOTAL ASSETS:842804757467409327240
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities60536050624438
Accounts payable15122120261419
Accrued liabilities2323262017168
Employee-related liabilities22171310181311
Debt113222 
Due to related parties      0
Other liabilities4542222
Other undisclosed current liabilities81756364493521
Total current liabilities:1461331301191158361
Noncurrent Liabilities
Long-term debt and lease obligation38738738716416216378
Long-term debt, excluding current maturities37737737615315215278
Finance lease, liability1110   
Operating lease, liability91010111011 
Liabilities, other than long-term debt28272726262626
Due to related parties27272626262626
Other liabilities11     
Business combination, contingent consideration, liability0000000
Other undisclosed noncurrent liabilities      79
Total noncurrent liabilities:415415413190189189183
Total liabilities:561548543309304271244
Stockholders' equity
Stockholders' equity attributable to parent28125621315710556(4)
Common stock0000000
Additional paid in capital1,0441,0281,0141,0171,001991978
Accumulated other comprehensive income (loss)(0)(0)(0)0(1)(0)(1)
Accumulated deficit(763)(772)(800)(859)(895)(934)(981)
Total stockholders' equity:28125621315710556(4)
TOTAL LIABILITIES AND EQUITY:842804757467409327240

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues11011413611612411283
Cost of revenue
(Cost of Goods and Services Sold)
    (0) (1)
Other undisclosed gross profit(38)      
Gross profit:7311413611612411283
Operating expenses(56)(80)(70)(75)(79)(60)(56)
Other undisclosed operating income    0 1
Operating income:16346541455227
Nonoperating income0000111
Foreign currency transaction gain, before tax    0  
Other nonoperating income 000111
Interest and debt expense(6)(6)(5)(4)(4)(4)(4)
Other undisclosed loss from continuing operations before equity method investments, income taxes(0)   (0)  
Income from continuing operations before equity method investments, income taxes:11286037414824
Other undisclosed income from continuing operations before income taxes    0  
Income from continuing operations before income taxes:11286037414824
Income tax expense(1)(0)(1)(1)(2)(1)(0)
Net income available to common stockholders, basic:10285936394724
Interest on convertible debt     2 
Net income available to common stockholders, diluted:10285936395024

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income:10285936394724
Other undisclosed comprehensive income (loss)(0)0(0)1(0)0(0)
Comprehensive income, net of tax, attributable to parent:10285936394723

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: